Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study

INTRODUCTION: Type I interferons (IFNs) are implicated in the pathogenesis of systemic sclerosis (SSc). MEDI-546 is an investigational human monoclonal antibody directed against the type I IFN receptor. This Phase 1 study evaluated the safety/tolerability, pharmacokinetics (PK), immunogenicity, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Avram, Geppert, Thomas, Schiopu, Elena, Frech, Tracy, Hsu, Vivien, Simms, Robert W, Peng, Stanford L, Yao, Yihong, Elgeioushi, Nairouz, Chang, Linda, Wang, Bing, Yoo, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978926/
https://www.ncbi.nlm.nih.gov/pubmed/24559157
http://dx.doi.org/10.1186/ar4492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978926/
https://www.ncbi.nlm.nih.gov/pubmed/24559157
http://dx.doi.org/10.1186/ar4492

Ejemplares similares